Login

AGILE THERAPEUTICS INC SEC Filings

Filed On Filing
13 Nov 2024 SC 13G/A
30 Sep 2024 15-12G
28 Aug 2024 RW
27 Aug 2024 EFFECT
27 Aug 2024 EFFECT
27 Aug 2024 EFFECT
26 Aug 2024 Form 4: Gilmore Geoffrey, Chief Administrative Officer

Returned 20,256 shares to the issuer ($30.8K)

26 Aug 2024 Form 4: Coiante Scott M, Chief Financial Officer

Returned 20,080 shares to the issuer ($30.5K)

26 Aug 2024 Form 4: Conway Robert G, Chief Supply Chain Officer

Returned 13,529 shares to the issuer ($20.6K)

26 Aug 2024 Form 4: Korner Paul, Chief Medical Officer

Returned 13,500 shares to the issuer ($20.5K)

26 Aug 2024 Form 4: Welsh Amy, Chief Commercial Officer

Returned 13,500 shares to the issuer ($20.5K)

26 Aug 2024 Form 4: Torrente Josephine, Director

Returned 987 shares to the issuer ($1.5K)

26 Aug 2024 Form 4: Barbari Sharon, Director

Returned 973 shares to the issuer ($1.48K)

26 Aug 2024 Form 4: Carson Sandra, Director

Returned 973 shares to the issuer ($1.48K)

26 Aug 2024 Form 4: Altomari Alfred, Chief Executive Officer

Returned 47,749 shares to the issuer ($72.6K)

26 Aug 2024 Form 4: Fischer Seth H. Z., Director

Returned 976 shares to the issuer ($1.48K)

26 Aug 2024 Form 4: Hubbard John W, Director

Returned 976 shares to the issuer ($1.48K)

26 Aug 2024 S-8 POS
26 Aug 2024 S-8 POS
26 Aug 2024 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support